MetLife Investment Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $778K | Buy |
|
|||||
|
2025
Q1 | $883K | Buy |
|
|||||
|
2024
Q4 | $779K | Buy |
|
|||||
|
2024
Q3 | $576K | Buy |
|
|||||
|
2024
Q2 | $336K | Buy |
|
|||||
|
2024
Q1 | $254K | Sell |
|
|||||
|
2023
Q4 | $346K | Hold |
|
|||||
|
2023
Q3 | $344K | Hold |
|
|||||
|
2023
Q2 | $590K | Buy |
|
|||||
|
2023
Q1 | $731K | Hold |
|
|||||
|
2022
Q4 | $684K | Hold |
|
|||||
|
2022
Q3 | $801K | Hold |
|
|||||
|
2022
Q2 | $788K | Sell |
|
|||||
|
2022
Q1 | $871K | Buy |
|
|||||
|
2021
Q4 | $662K | Hold |
|
|||||
|
2021
Q3 | $517K | Hold |
|
|||||
|
2021
Q2 | $311K | Hold |
|
|||||
|
2021
Q1 | $532K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $394K | Buy |
|
|||||
|
2020
Q2 | $385K | Hold |
|
|||||
|
2020
Q1 | $275K | Hold |
|
|||||
|
2019
Q4 | $268K | Hold |
|
|||||
|
2019
Q3 | $218K | Hold |
|
|||||
|
2019
Q2 | $379K | Hold |
|
|||||
|
2019
Q1 | $426K | Hold |
|
|||||
|
2018
Q4 | $426K | Hold |
|
|||||
|
2018
Q3 | $541K | Hold |
|
|||||
|
2018
Q2 | $514K | Buy |
|
|||||
|
2018
Q1 | $367K | Hold |
|
|||||
|
2017
Q4 | $346K | Buy |
|